What does DR. T. PETIT - DR. D. GEUSENS do?

DR. T. PETIT - DR. D. GEUSENS is a specialist medical practice in Heusden-Zolder. Private Limited, started on 3 February 2022, 1 establishment.

What is the address of DR. T. PETIT - DR. D. GEUSENS?

The registered office of DR. T. PETIT - DR. D. GEUSENS is located at Dahlialaan 16, 3550 Heusden-Zolder.

Is DR. T. PETIT - DR. D. GEUSENS still active?

Yes. According to the CBE (18 September 2026) DR. T. PETIT - DR. D. GEUSENS is active, legal situation “Normale toestand”, started on 3 February 2022.

Is DR. T. PETIT - DR. D. GEUSENS registered on Peppol?

Yes, DR. T. PETIT - DR. D. GEUSENS is registered on the Peppol network with ID 0208:0781547707.

What is the enterprise number of DR. T. PETIT - DR. D. GEUSENS?

The enterprise number of DR. T. PETIT - DR. D. GEUSENS is BE0781547707.

When was DR. T. PETIT - DR. D. GEUSENS founded?

DR. T. PETIT - DR. D. GEUSENS was founded on 3 February 2022.

Who are the directors of DR. T. PETIT - DR. D. GEUSENS?

According to the 2025 annual accounts, the directors of DR. T. PETIT - DR. D. GEUSENS are: Dorien Geusens, Thibault Petit.

Is DR. T. PETIT - DR. D. GEUSENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 February 2022; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. T. PETIT - DR. D. GEUSENS make in 2025?

DR. T. PETIT - DR. D. GEUSENS posted a profit after taxes of € 307,379 in financial year 2025.

What is the revenue of DR. T. PETIT - DR. D. GEUSENS?

As a small company, DR. T. PETIT - DR. D. GEUSENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 413,631.

DR. T. PETIT - DR. D. GEUSENS (Private Limited)

Dossier DR. T. PETIT - DR. D. GEUSENS, printed on 18 September 2026 from databakkes.be/en/0781547707/dr-t-petit-dr-d-geusens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. T. PETIT - DR. D. GEUSENS from Heusden-Zolder, company number BE0781547707, closed financial year 2025 with a result of € 307,379 after tax. For that financial year DR. T. PETIT - DR. D. GEUSENS recorded a gross margin of € 413,631 and equity of € 10,379. Compared with financial year 2024, the result moved from € 273,196 to € 307,379. Profitable, and profit is growing. The buffer shrank hard: equity is 98 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Shrank hard

€ 10,379

▼ 98% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 307,379

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 653,094

▲ 40% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 918,175 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 6,887

▼ 41% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 15,139

▲ 12% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,761

▲ 96% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 167,109

▲ € 158,814 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 60,841 Gross margin 2022: € 60,841 First fiscal year in the series	€ 392,277 Gross margin 2023: € 392,277 ▲ € 331,436 vs 2022 (€ 60,841) Favourable step	€ 364,802 Gross margin 2024: € 364,802 ▼ 7% vs 2023 (€ 392,277) Unfavourable step	€ 413,631 Gross margin 2025: € 413,631 ▲ 13% vs 2024 (€ 364,802) Favourable step	▲ 13%
Profit after taxes	€ 47,177 Profit after taxes 2022: € 47,177 First fiscal year in the series	€ 295,802 Profit after taxes 2023: € 295,802 ▲ € 248,625 vs 2022 (€ 47,177) Favourable step	€ 273,196 Profit after taxes 2024: € 273,196 ▼ 8% vs 2023 (€ 295,802) Unfavourable step	€ 307,379 Profit after taxes 2025: € 307,379 ▲ 13% vs 2024 (€ 273,196) Favourable step	▲ 13%
Equity	€ 52,177 Equity 2022: € 52,177 First fiscal year in the series	€ 347,979 Equity 2023: € 347,979 ▲ € 295,802 vs 2022 (€ 52,177) Favourable step	€ 621,175 Equity 2024: € 621,175 ▲ 79% vs 2023 (€ 347,979) Favourable step	€ 10,379 Equity 2025: € 10,379 ▼ 98% vs 2024 (€ 621,175) Unfavourable step	▼ 98%
Total debts	€ 34,438 Total debts 2022: € 34,438 First fiscal year in the series	€ 71,111 Total debts 2023: € 71,111 ▲ 106% vs 2022 (€ 34,438) Unfavourable step	€ 29,455 Total debts 2024: € 29,455 ▼ 59% vs 2023 (€ 71,111) Favourable step	€ 964,173 Total debts 2025: € 964,173 ▲ € 934,718 vs 2024 (€ 29,455) Unfavourable step	▲ € 934,718
Cash	€ 57,376 Cash 2022: € 57,376 First fiscal year in the series	€ 219,788 Cash 2023: € 219,788 ▲ 283% vs 2022 (€ 57,376) Favourable step	€ 466,007 Cash 2024: € 466,007 ▲ 112% vs 2023 (€ 219,788) Favourable step	€ 653,094 Cash 2025: € 653,094 ▲ 40% vs 2024 (€ 466,007) Favourable step	▲ 40%
Retained profit	€ 47,177 Retained profit 2022: € 47,177 First fiscal year in the series	€ 342,979 Retained profit 2023: € 342,979 ▲ € 295,802 vs 2022 (€ 47,177) Favourable step	€ 616,175 Retained profit 2024: € 616,175 ▲ 80% vs 2023 (€ 342,979) Favourable step	€ 5,379 Retained profit 2025: € 5,379 ▼ 99% vs 2024 (€ 616,175) Unfavourable step	▼ 99%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 918,175 Dividend 2025: € 918,175 Unchanged (€ 0) Unchanged
Bank debt	€ 6,690 Bank debt 2022: € 6,690 First fiscal year in the series	€ 8,454 Bank debt 2023: € 8,454 ▲ 26% vs 2022 (€ 6,690) Unfavourable step	€ 13,523 Bank debt 2024: € 13,523 ▲ 60% vs 2023 (€ 8,454) Unfavourable step	€ 15,139 Bank debt 2025: € 15,139 ▲ 12% vs 2024 (€ 13,523) Unfavourable step	▲ 12%
Balance sheet total	€ 86,615 Balance sheet total 2022: € 86,615 First fiscal year in the series	€ 419,090 Balance sheet total 2023: € 419,090 ▲ € 332,475 vs 2022 (€ 86,615) Unchanged	€ 650,630 Balance sheet total 2024: € 650,630 ▲ 55% vs 2023 (€ 419,090) Unchanged	€ 974,552 Balance sheet total 2025: € 974,552 ▲ 50% vs 2024 (€ 650,630) Unchanged	▲ 50%

Key figures of DR. T. PETIT - DR. D. GEUSENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. T. PETIT - DR. D. GEUSENS?

What happened at DR. T. PETIT - DR. D. GEUSENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 307,379 (▲ 13% vs 2024). Source: NBB ↗
Feb 3, 2022 New establishment in Heusden-Zolder. KBO
Feb 3, 2022 Start of the company according to the CBE. KBO
2022 Dorien Geusens became a director. NBB
2022 Thibault Petit became a director. NBB

In short

From € 47,177 profit in 2022 to € 307,379 profit in 2025.

Paid € 288,127 in corporate taxes since 2022.

Best year ever: 2025, with € 307,379 profit.

Paid out € 918,175 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. T. PETIT - DR. D. GEUSENS? We notify you, reason included.

Follow DR. T. PETIT - DR. D. GEUSENS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Dorien Geusens Thibault Petit

DR. T. PETIT - DR. D. GEUSENS

Behind DR. T. PETIT - DR. D. GEUSENS are Dorien Geusens and Thibault Petit.

See the full network in the app

Directors

According to the 2025 annual accounts

Dorien Geusens

Director

since 2022

Thibault Petit

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Dahlialaan 16

3550 Heusden-Zolder

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0781.547.707
VAT number: BE 0781.547.707
Registered office: Dahlialaan 16, 3550 Heusden-Zolder
Names & denominations: DR. T. PETIT - DR. D. GEUSENS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 February 2022
Peppol: Active · Active since 16 Sept 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗